Disc Medicine, Inc. (IRON) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Disc Medicine, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
  • Disc Medicine, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 4.91 %, a 73.6% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 4.91 -13.7 -73.6% Mar 31, 2024
Q4 2023 4.91 +61.3 Dec 31, 2023
Q3 2023 5.7 +16.8 Sep 30, 2023
Q2 2023 7.18 +68 Jun 30, 2023
Q1 2023 18.6 -16.8 -47.4% Mar 31, 2023
Q4 2022 -56.4 -71.8 -466% Dec 31, 2022
Q3 2022 -11.1 -28.7 -163% Sep 30, 2022
Q2 2022 -60.8 -84.1 -361% Jun 30, 2022
Q1 2022 35.4 Mar 31, 2022
Q4 2021 15.4 Dec 31, 2021
Q3 2021 17.7 Sep 30, 2021
Q2 2021 23.3 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.